{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:08Z","timestamp":1790629748971,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bmc.2019.07.049","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:41:37Z","timestamp":1564494097000},"page":"4185-4199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structure-activity analysis of peptidic Chlamydia HtrA inhibitors"],"prefix":"10.1016","volume":"27","author":[{"given":"Ayodeji A.","family":"Agbowuro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Peel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Mazraani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Springwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McCaughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan B.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina M.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.A.","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bmc.2019.07.049_b0005","first-page":"799","article-title":"Characteristics of the chlamydia trachomatis species \u2013 immunopathology and infections","volume":"21","author":"Choroszy-Krol","year":"2012","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.049_b0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1574-6976.12059","article-title":"Chlamydial metabolism revisited: interspecies metabolic variability and developmental stage-specific physiologic activities","volume":"38","author":"Omsland","year":"2014","journal-title":"Fems Microbiol Rev"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.049_b0015","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CMR.00035-15","article-title":"Human and pathogen factors associated with chlamydia trachomatis-related infertility in women","volume":"28","author":"Menon","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.bmc.2019.07.049_b0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijo.IJO_870_16","article-title":"Chlamydial eye infections: current perspectives","volume":"65","author":"Satpathy","year":"2017","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.049_b0025","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/infdis\/168.5.1231","article-title":"Evidence that chlamydia-pneumoniae causes pneumonia and bronchitis","volume":"168","author":"Grayston","year":"1993","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.049_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrmicro796","article-title":"Chlamydia pneumoniae\u2013an infectious risk factor for atherosclerosis?","volume":"2","author":"Campbell","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"15","key":"10.1016\/j.bmc.2019.07.049_b0035","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1417301112","article-title":"Ongoing unraveling of a continental fauna: decline and extinction of australian mammals since european settlement","volume":"112","author":"Woinarski","year":"2015","journal-title":"P Natl Acad Sci Usa"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.049_b0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-1135(98)00302-2","article-title":"Epizootiology of chlamydia infections in two free-range koala populations","volume":"65","author":"Jackson","year":"1999","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.049_b0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0723-2020(99)80024-1","article-title":"Characterization of the koala biovar of chlamydia pneumoniae at four Gene Loci\u2013Ompavd4, Ompb, 16s Rrna, groesl spacer region","volume":"22","author":"Wardrop","year":"1999","journal-title":"Syst Appl Microbiol"},{"issue":"12","key":"10.1016\/j.bmc.2019.07.049_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections In 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"Plos One"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.049_b0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/fmb.10.96","article-title":"Antibiotic resistance in chlamydiae","volume":"5","author":"Sandoz","year":"2010","journal-title":"Fut Microbiol"},{"issue":"3","key":"10.1016\/j.bmc.2019.07.049_b0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sextrans-2011-050385","article-title":"Azithromycin antimicrobial resistance and genital chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy","volume":"88","author":"Horner","year":"2012","journal-title":"Sex Transm Infect"},{"issue":"33","key":"10.1016\/j.bmc.2019.07.049_b0065","article-title":"Sexually transmitted diseases treatment guidelines, 2015 (Vol 64, Pg 1, 2015)","volume":"64","author":"Workowski","year":"2015","journal-title":"Mmwr-Morbid Mortal W"},{"issue":"3","key":"10.1016\/j.bmc.2019.07.049_b0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in neisseria gonorrhoeae in the 21st Century: past, evolution and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"8\u20139","key":"10.1016\/j.bmc.2019.07.049_b0075","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2340\/00015555-2746","article-title":"Mycoplasma genitalium and macrolide resistance-associated mutations in the sk\u00e5ne region of southern Sweden 2015","volume":"97","author":"Forslund","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"18","key":"10.1016\/j.bmc.2019.07.049_b0080","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.febslet.2007.06.039","article-title":"The temperature activated Htra protease from pathogen chlamydia trachomatis acts as both A chaperone and protease At 37 degrees C","volume":"581","author":"Huston","year":"2007","journal-title":"Febs Lett"},{"issue":"9","key":"10.1016\/j.bmc.2019.07.049_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024547","article-title":"Unique residues involved in activation of the multitasking protease\/chaperone htra from chlamydia trachomatis","volume":"6","author":"Huston","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.049_b0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/mmi.12306","article-title":"Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to chlamydia trachomatis","volume":"89","author":"Gloeckl","year":"2013","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmc.2019.07.049_b0095","first-page":"6","article-title":"Chlamydia serine protease inhibitor, targeting Htra as a new treatment for koala Chlamydia infection","author":"Lawrence","year":"2016","journal-title":"Sci Rep-Uk"},{"issue":"14","key":"10.1016\/j.bmc.2019.07.049_b0100","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1021\/jm300599x","article-title":"Human neutrophil elastase phosphonic inhibitors with improved potency of action","volume":"55","author":"Winiarski","year":"2012","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2019.07.049_b0105","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/jm9603274","article-title":"Potent thrombin inhibitors that probe the S1 \u2018subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group 1","volume":"39","author":"Costanzo","year":"1996","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2019.07.049_b0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0960-894X(00)00074-3","article-title":"\u0391-ketoamides, \u0391-ketoesters and \u0391-diketones As Hcv Ns3 protease inhibitors","volume":"10","author":"Han","year":"2000","journal-title":"Bioorganic Med Chem Lett"},{"issue":"17","key":"10.1016\/j.bmc.2019.07.049_b0115","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0960-894X(02)00461-4","article-title":"Design and synthesis of conformationally restricted eight-membered ring diketones as potential serine protease inhibitors","volume":"12","author":"Pearson","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.049_b0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/ar700109k","article-title":"Challenges in modern drug discovery: a case study of boceprevir, An Hcv protease inhibitor for the treatment of hepatitis C virus infection","volume":"41","author":"Njoroge","year":"2008","journal-title":"Accounts Chem Res"},{"issue":"21","key":"10.1016\/j.bmc.2019.07.049_b0125","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/S0040-4020(01)80649-9","article-title":"A new efficient synthesis of ethyl \u0392-carboline-3-carboxylate (\u0392-Cce) and methyl 4-methyl-\u03b2-carboline-3-carboxylate (4-Methyl-\u0392-Ccm) starting Fr","volume":"50","author":"Dekhane","year":"1994","journal-title":"Tetrahedron"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.049_b0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/psc.751","article-title":"The epimerization of peptide aldehydes\u2014a systematic study","volume":"12","author":"Ganneau","year":"2006","journal-title":"J Pept Sci"},{"issue":"20","key":"10.1016\/j.bmc.2019.07.049_b0135","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.1021\/ja00202a053","article-title":"Intermolecular pinacol cross coupling of electronically similar aldehydes. an efficient and stereoselective synthesis of 1, 2-diols employing a practical vanadium (Ii) reagent","volume":"111","author":"Freudenberger","year":"1989","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.049_b0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(04)00120-5","article-title":"The development of proteasome inhibitors as anticancer drugs","volume":"5","author":"Adams","year":"2004","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.049_b0145","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/med.21475","article-title":"Proteases and protease inhibitors in infectious diseases","volume":"38","author":"Agbowuro","year":"2018","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.bmc.2019.07.049_b0150","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/j.1460-2075.1986.tb04521.x","article-title":"X-ray crystal structure of the complex of human leukocyte elastase (Pmn Elastase) and the third domain of the turkey ovomucoid inhibitor","volume":"5","author":"Bode","year":"1986","journal-title":"Embo J"},{"issue":"4","key":"10.1016\/j.bmc.2019.07.049_b0155","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.bmc.2019.07.049_b0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9120(86)80002-9","article-title":"Chymotrypsin: molecular and catalytic properties","volume":"19","author":"Appel","year":"1986","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.049_b0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/jm00001a013","article-title":"Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 2. Effect of varying the heterocyclic ring on in-vitro potency","volume":"38","author":"Edwards","year":"1995","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.049_b0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nsmb.1839","article-title":"Determinants of structural and functional plasticity of a widely conserved protease chaperone complex","volume":"17","author":"Merdanovic","year":"2010","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"10.1016\/j.bmc.2019.07.049_b0175","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/molecules22071192","article-title":"Assessment of enzyme inhibition: a review with examples from the development of monoamine oxidase and cholinesterase inhibitory drugs","volume":"22","author":"Ramsay","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.07.049_b0180","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.tet.2017.10.031","article-title":"stereochemical basis for the anti-chlamydial activity of the phosphonate protease inhibitor Jo146","volume":"74","author":"Agbowuro","year":"2018","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.049_b0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2144\/97231bm14","article-title":"Rapid microplate assay for substrates and inhibitors of proteinase mixtures","volume":"23","author":"Oppert","year":"1997","journal-title":"Biotechniques"},{"issue":"3","key":"10.1016\/j.bmc.2019.07.049_b0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.bmc.2019.07.049_b0195","first-page":"10","article-title":"The active site residue V266 of chlamydial Htra is critical for substrate binding during both in vitro and in vivo conditions","volume":"22","author":"Gloeckl","year":"2012","journal-title":"J Mol Microbiol Biotechnol"},{"issue":"5","key":"10.1016\/j.bmc.2019.07.049_b0200","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1021\/ja00031a046","article-title":"And kinetic evaluation of a unique class of elastase inhibitors, the peptidyl. Alpha.-ketobenzoxazoles, and the x-ray crystal structure of the covalent complex between porcine pancreatic elastase and Ac-Ala-Pro-Val-2-benzoxazole","volume":"114","author":"Edwards","year":"1992","journal-title":"J Am Chem Soc"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619303335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619303335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:04:29Z","timestamp":1760835869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619303335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0968089619303335"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.049","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity analysis of peptidic Chlamydia HtrA inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}